Global GnRH Agonist Supply, Demand and Key Producers, 2023-2029
The global GnRH Agonist market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
GnRH, also known as gonadotropin-releasing hormone, is a peptide hormone secreted by the hypothalamus, which further stimulates the pituitary gland to release and synthesize gonadotropins, including follicle-stimulating hormone and luteinizing hormone. Controls the function of the ovary and the function of the testis. GnRH agonists are generally referred to as gonadotropin-releasing hormone agonists. Gonadorelin-releasing hormone agonists generally include triptorelin acetate injection, gonadorelin for injection, leuprolide acetate microspheres for injection and other drugs.
This report studies the global GnRH Agonist production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for GnRH Agonist, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of GnRH Agonist that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global GnRH Agonist total production and demand, 2018-2029, (Kilogram)
Global GnRH Agonist total production value, 2018-2029, (USD Million)
Global GnRH Agonist production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (Kilogram)
Global GnRH Agonist consumption by region & country, CAGR, 2018-2029 & (Kilogram)
U.S. VS China: GnRH Agonist domestic production, consumption, key domestic manufacturers and share
Global GnRH Agonist production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (Kilogram)
Global GnRH Agonist production by Type, production, value, CAGR, 2018-2029, (USD Million) & (Kilogram)
Global GnRH Agonist production by Application production, value, CAGR, 2018-2029, (USD Million) & (Kilogram).
This reports profiles key players in the global GnRH Agonist market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, AbbVie, AstraZeneca, Ferring, TerSera Therapeutics, Astellas Pharma, Takeda, LIVZON and Ipsen, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World GnRH Agonist market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Kilogram) and average price (US$/mg) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global GnRH Agonist Market, By Region:
1. How big is the global GnRH Agonist market?
2. What is the demand of the global GnRH Agonist market?
3. What is the year over year growth of the global GnRH Agonist market?
4. What is the production and production value of the global GnRH Agonist market?
5. Who are the key producers in the global GnRH Agonist market?
6. What are the growth factors driving the market demand?
GnRH, also known as gonadotropin-releasing hormone, is a peptide hormone secreted by the hypothalamus, which further stimulates the pituitary gland to release and synthesize gonadotropins, including follicle-stimulating hormone and luteinizing hormone. Controls the function of the ovary and the function of the testis. GnRH agonists are generally referred to as gonadotropin-releasing hormone agonists. Gonadorelin-releasing hormone agonists generally include triptorelin acetate injection, gonadorelin for injection, leuprolide acetate microspheres for injection and other drugs.
This report studies the global GnRH Agonist production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for GnRH Agonist, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of GnRH Agonist that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global GnRH Agonist total production and demand, 2018-2029, (Kilogram)
Global GnRH Agonist total production value, 2018-2029, (USD Million)
Global GnRH Agonist production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (Kilogram)
Global GnRH Agonist consumption by region & country, CAGR, 2018-2029 & (Kilogram)
U.S. VS China: GnRH Agonist domestic production, consumption, key domestic manufacturers and share
Global GnRH Agonist production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (Kilogram)
Global GnRH Agonist production by Type, production, value, CAGR, 2018-2029, (USD Million) & (Kilogram)
Global GnRH Agonist production by Application production, value, CAGR, 2018-2029, (USD Million) & (Kilogram).
This reports profiles key players in the global GnRH Agonist market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, AbbVie, AstraZeneca, Ferring, TerSera Therapeutics, Astellas Pharma, Takeda, LIVZON and Ipsen, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World GnRH Agonist market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Kilogram) and average price (US$/mg) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global GnRH Agonist Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Prostap
- Zoladex
- Triptorelin
- Histrelin
- Nafarelin
- Others
- For Human
- For Veterinary
- Pfizer
- AbbVie
- AstraZeneca
- Ferring
- TerSera Therapeutics
- Astellas Pharma
- Takeda
- LIVZON
- Ipsen
- Sanofi
- Endo
- Tocris Bioscience
- Sigma-Aldrich
- MedChem Express
- Arbor Pharmaceuticals
1. How big is the global GnRH Agonist market?
2. What is the demand of the global GnRH Agonist market?
3. What is the year over year growth of the global GnRH Agonist market?
4. What is the production and production value of the global GnRH Agonist market?
5. Who are the key producers in the global GnRH Agonist market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 GnRH Agonist Introduction
1.2 World GnRH Agonist Supply & Forecast
1.2.1 World GnRH Agonist Production Value (2018 & 2022 & 2029)
1.2.2 World GnRH Agonist Production (2018-2029)
1.2.3 World GnRH Agonist Pricing Trends (2018-2029)
1.3 World GnRH Agonist Production by Region (Based on Production Site)
1.3.1 World GnRH Agonist Production Value by Region (2018-2029)
1.3.2 World GnRH Agonist Production by Region (2018-2029)
1.3.3 World GnRH Agonist Average Price by Region (2018-2029)
1.3.4 North America GnRH Agonist Production (2018-2029)
1.3.5 Europe GnRH Agonist Production (2018-2029)
1.3.6 China GnRH Agonist Production (2018-2029)
1.3.7 Japan GnRH Agonist Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 GnRH Agonist Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 GnRH Agonist Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World GnRH Agonist Demand (2018-2029)
2.2 World GnRH Agonist Consumption by Region
2.2.1 World GnRH Agonist Consumption by Region (2018-2023)
2.2.2 World GnRH Agonist Consumption Forecast by Region (2024-2029)
2.3 United States GnRH Agonist Consumption (2018-2029)
2.4 China GnRH Agonist Consumption (2018-2029)
2.5 Europe GnRH Agonist Consumption (2018-2029)
2.6 Japan GnRH Agonist Consumption (2018-2029)
2.7 South Korea GnRH Agonist Consumption (2018-2029)
2.8 ASEAN GnRH Agonist Consumption (2018-2029)
2.9 India GnRH Agonist Consumption (2018-2029)
3 WORLD GNRH AGONIST MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World GnRH Agonist Production Value by Manufacturer (2018-2023)
3.2 World GnRH Agonist Production by Manufacturer (2018-2023)
3.3 World GnRH Agonist Average Price by Manufacturer (2018-2023)
3.4 GnRH Agonist Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global GnRH Agonist Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for GnRH Agonist in 2022
3.5.3 Global Concentration Ratios (CR8) for GnRH Agonist in 2022
3.6 GnRH Agonist Market: Overall Company Footprint Analysis
3.6.1 GnRH Agonist Market: Region Footprint
3.6.2 GnRH Agonist Market: Company Product Type Footprint
3.6.3 GnRH Agonist Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: GnRH Agonist Production Value Comparison
4.1.1 United States VS China: GnRH Agonist Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: GnRH Agonist Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: GnRH Agonist Production Comparison
4.2.1 United States VS China: GnRH Agonist Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: GnRH Agonist Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: GnRH Agonist Consumption Comparison
4.3.1 United States VS China: GnRH Agonist Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: GnRH Agonist Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based GnRH Agonist Manufacturers and Market Share, 2018-2023
4.4.1 United States Based GnRH Agonist Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers GnRH Agonist Production Value (2018-2023)
4.4.3 United States Based Manufacturers GnRH Agonist Production (2018-2023)
4.5 China Based GnRH Agonist Manufacturers and Market Share
4.5.1 China Based GnRH Agonist Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers GnRH Agonist Production Value (2018-2023)
4.5.3 China Based Manufacturers GnRH Agonist Production (2018-2023)
4.6 Rest of World Based GnRH Agonist Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based GnRH Agonist Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers GnRH Agonist Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers GnRH Agonist Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World GnRH Agonist Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Prostap
5.2.2 Zoladex
5.2.3 Triptorelin
5.2.4 Histrelin
5.2.5 Nafarelin
5.2.6 Others
5.3 Market Segment by Type
5.3.1 World GnRH Agonist Production by Type (2018-2029)
5.3.2 World GnRH Agonist Production Value by Type (2018-2029)
5.3.3 World GnRH Agonist Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World GnRH Agonist Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 For Human
6.2.2 For Veterinary
6.3 Market Segment by Application
6.3.1 World GnRH Agonist Production by Application (2018-2029)
6.3.2 World GnRH Agonist Production Value by Application (2018-2029)
6.3.3 World GnRH Agonist Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Pfizer
7.1.1 Pfizer Details
7.1.2 Pfizer Major Business
7.1.3 Pfizer GnRH Agonist Product and Services
7.1.4 Pfizer GnRH Agonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Pfizer Recent Developments/Updates
7.1.6 Pfizer Competitive Strengths & Weaknesses
7.2 AbbVie
7.2.1 AbbVie Details
7.2.2 AbbVie Major Business
7.2.3 AbbVie GnRH Agonist Product and Services
7.2.4 AbbVie GnRH Agonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 AbbVie Recent Developments/Updates
7.2.6 AbbVie Competitive Strengths & Weaknesses
7.3 AstraZeneca
7.3.1 AstraZeneca Details
7.3.2 AstraZeneca Major Business
7.3.3 AstraZeneca GnRH Agonist Product and Services
7.3.4 AstraZeneca GnRH Agonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 AstraZeneca Recent Developments/Updates
7.3.6 AstraZeneca Competitive Strengths & Weaknesses
7.4 Ferring
7.4.1 Ferring Details
7.4.2 Ferring Major Business
7.4.3 Ferring GnRH Agonist Product and Services
7.4.4 Ferring GnRH Agonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Ferring Recent Developments/Updates
7.4.6 Ferring Competitive Strengths & Weaknesses
7.5 TerSera Therapeutics
7.5.1 TerSera Therapeutics Details
7.5.2 TerSera Therapeutics Major Business
7.5.3 TerSera Therapeutics GnRH Agonist Product and Services
7.5.4 TerSera Therapeutics GnRH Agonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 TerSera Therapeutics Recent Developments/Updates
7.5.6 TerSera Therapeutics Competitive Strengths & Weaknesses
7.6 Astellas Pharma
7.6.1 Astellas Pharma Details
7.6.2 Astellas Pharma Major Business
7.6.3 Astellas Pharma GnRH Agonist Product and Services
7.6.4 Astellas Pharma GnRH Agonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Astellas Pharma Recent Developments/Updates
7.6.6 Astellas Pharma Competitive Strengths & Weaknesses
7.7 Takeda
7.7.1 Takeda Details
7.7.2 Takeda Major Business
7.7.3 Takeda GnRH Agonist Product and Services
7.7.4 Takeda GnRH Agonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Takeda Recent Developments/Updates
7.7.6 Takeda Competitive Strengths & Weaknesses
7.8 LIVZON
7.8.1 LIVZON Details
7.8.2 LIVZON Major Business
7.8.3 LIVZON GnRH Agonist Product and Services
7.8.4 LIVZON GnRH Agonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 LIVZON Recent Developments/Updates
7.8.6 LIVZON Competitive Strengths & Weaknesses
7.9 Ipsen
7.9.1 Ipsen Details
7.9.2 Ipsen Major Business
7.9.3 Ipsen GnRH Agonist Product and Services
7.9.4 Ipsen GnRH Agonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Ipsen Recent Developments/Updates
7.9.6 Ipsen Competitive Strengths & Weaknesses
7.10 Sanofi
7.10.1 Sanofi Details
7.10.2 Sanofi Major Business
7.10.3 Sanofi GnRH Agonist Product and Services
7.10.4 Sanofi GnRH Agonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Sanofi Recent Developments/Updates
7.10.6 Sanofi Competitive Strengths & Weaknesses
7.11 Endo
7.11.1 Endo Details
7.11.2 Endo Major Business
7.11.3 Endo GnRH Agonist Product and Services
7.11.4 Endo GnRH Agonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Endo Recent Developments/Updates
7.11.6 Endo Competitive Strengths & Weaknesses
7.12 Tocris Bioscience
7.12.1 Tocris Bioscience Details
7.12.2 Tocris Bioscience Major Business
7.12.3 Tocris Bioscience GnRH Agonist Product and Services
7.12.4 Tocris Bioscience GnRH Agonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Tocris Bioscience Recent Developments/Updates
7.12.6 Tocris Bioscience Competitive Strengths & Weaknesses
7.13 Sigma-Aldrich
7.13.1 Sigma-Aldrich Details
7.13.2 Sigma-Aldrich Major Business
7.13.3 Sigma-Aldrich GnRH Agonist Product and Services
7.13.4 Sigma-Aldrich GnRH Agonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Sigma-Aldrich Recent Developments/Updates
7.13.6 Sigma-Aldrich Competitive Strengths & Weaknesses
7.14 MedChem Express
7.14.1 MedChem Express Details
7.14.2 MedChem Express Major Business
7.14.3 MedChem Express GnRH Agonist Product and Services
7.14.4 MedChem Express GnRH Agonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 MedChem Express Recent Developments/Updates
7.14.6 MedChem Express Competitive Strengths & Weaknesses
7.15 Arbor Pharmaceuticals
7.15.1 Arbor Pharmaceuticals Details
7.15.2 Arbor Pharmaceuticals Major Business
7.15.3 Arbor Pharmaceuticals GnRH Agonist Product and Services
7.15.4 Arbor Pharmaceuticals GnRH Agonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Arbor Pharmaceuticals Recent Developments/Updates
7.15.6 Arbor Pharmaceuticals Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 GnRH Agonist Industry Chain
8.2 GnRH Agonist Upstream Analysis
8.2.1 GnRH Agonist Core Raw Materials
8.2.2 Main Manufacturers of GnRH Agonist Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 GnRH Agonist Production Mode
8.6 GnRH Agonist Procurement Model
8.7 GnRH Agonist Industry Sales Model and Sales Channels
8.7.1 GnRH Agonist Sales Model
8.7.2 GnRH Agonist Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 GnRH Agonist Introduction
1.2 World GnRH Agonist Supply & Forecast
1.2.1 World GnRH Agonist Production Value (2018 & 2022 & 2029)
1.2.2 World GnRH Agonist Production (2018-2029)
1.2.3 World GnRH Agonist Pricing Trends (2018-2029)
1.3 World GnRH Agonist Production by Region (Based on Production Site)
1.3.1 World GnRH Agonist Production Value by Region (2018-2029)
1.3.2 World GnRH Agonist Production by Region (2018-2029)
1.3.3 World GnRH Agonist Average Price by Region (2018-2029)
1.3.4 North America GnRH Agonist Production (2018-2029)
1.3.5 Europe GnRH Agonist Production (2018-2029)
1.3.6 China GnRH Agonist Production (2018-2029)
1.3.7 Japan GnRH Agonist Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 GnRH Agonist Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 GnRH Agonist Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World GnRH Agonist Demand (2018-2029)
2.2 World GnRH Agonist Consumption by Region
2.2.1 World GnRH Agonist Consumption by Region (2018-2023)
2.2.2 World GnRH Agonist Consumption Forecast by Region (2024-2029)
2.3 United States GnRH Agonist Consumption (2018-2029)
2.4 China GnRH Agonist Consumption (2018-2029)
2.5 Europe GnRH Agonist Consumption (2018-2029)
2.6 Japan GnRH Agonist Consumption (2018-2029)
2.7 South Korea GnRH Agonist Consumption (2018-2029)
2.8 ASEAN GnRH Agonist Consumption (2018-2029)
2.9 India GnRH Agonist Consumption (2018-2029)
3 WORLD GNRH AGONIST MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World GnRH Agonist Production Value by Manufacturer (2018-2023)
3.2 World GnRH Agonist Production by Manufacturer (2018-2023)
3.3 World GnRH Agonist Average Price by Manufacturer (2018-2023)
3.4 GnRH Agonist Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global GnRH Agonist Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for GnRH Agonist in 2022
3.5.3 Global Concentration Ratios (CR8) for GnRH Agonist in 2022
3.6 GnRH Agonist Market: Overall Company Footprint Analysis
3.6.1 GnRH Agonist Market: Region Footprint
3.6.2 GnRH Agonist Market: Company Product Type Footprint
3.6.3 GnRH Agonist Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: GnRH Agonist Production Value Comparison
4.1.1 United States VS China: GnRH Agonist Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: GnRH Agonist Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: GnRH Agonist Production Comparison
4.2.1 United States VS China: GnRH Agonist Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: GnRH Agonist Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: GnRH Agonist Consumption Comparison
4.3.1 United States VS China: GnRH Agonist Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: GnRH Agonist Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based GnRH Agonist Manufacturers and Market Share, 2018-2023
4.4.1 United States Based GnRH Agonist Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers GnRH Agonist Production Value (2018-2023)
4.4.3 United States Based Manufacturers GnRH Agonist Production (2018-2023)
4.5 China Based GnRH Agonist Manufacturers and Market Share
4.5.1 China Based GnRH Agonist Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers GnRH Agonist Production Value (2018-2023)
4.5.3 China Based Manufacturers GnRH Agonist Production (2018-2023)
4.6 Rest of World Based GnRH Agonist Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based GnRH Agonist Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers GnRH Agonist Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers GnRH Agonist Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World GnRH Agonist Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Prostap
5.2.2 Zoladex
5.2.3 Triptorelin
5.2.4 Histrelin
5.2.5 Nafarelin
5.2.6 Others
5.3 Market Segment by Type
5.3.1 World GnRH Agonist Production by Type (2018-2029)
5.3.2 World GnRH Agonist Production Value by Type (2018-2029)
5.3.3 World GnRH Agonist Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World GnRH Agonist Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 For Human
6.2.2 For Veterinary
6.3 Market Segment by Application
6.3.1 World GnRH Agonist Production by Application (2018-2029)
6.3.2 World GnRH Agonist Production Value by Application (2018-2029)
6.3.3 World GnRH Agonist Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Pfizer
7.1.1 Pfizer Details
7.1.2 Pfizer Major Business
7.1.3 Pfizer GnRH Agonist Product and Services
7.1.4 Pfizer GnRH Agonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Pfizer Recent Developments/Updates
7.1.6 Pfizer Competitive Strengths & Weaknesses
7.2 AbbVie
7.2.1 AbbVie Details
7.2.2 AbbVie Major Business
7.2.3 AbbVie GnRH Agonist Product and Services
7.2.4 AbbVie GnRH Agonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 AbbVie Recent Developments/Updates
7.2.6 AbbVie Competitive Strengths & Weaknesses
7.3 AstraZeneca
7.3.1 AstraZeneca Details
7.3.2 AstraZeneca Major Business
7.3.3 AstraZeneca GnRH Agonist Product and Services
7.3.4 AstraZeneca GnRH Agonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 AstraZeneca Recent Developments/Updates
7.3.6 AstraZeneca Competitive Strengths & Weaknesses
7.4 Ferring
7.4.1 Ferring Details
7.4.2 Ferring Major Business
7.4.3 Ferring GnRH Agonist Product and Services
7.4.4 Ferring GnRH Agonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Ferring Recent Developments/Updates
7.4.6 Ferring Competitive Strengths & Weaknesses
7.5 TerSera Therapeutics
7.5.1 TerSera Therapeutics Details
7.5.2 TerSera Therapeutics Major Business
7.5.3 TerSera Therapeutics GnRH Agonist Product and Services
7.5.4 TerSera Therapeutics GnRH Agonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 TerSera Therapeutics Recent Developments/Updates
7.5.6 TerSera Therapeutics Competitive Strengths & Weaknesses
7.6 Astellas Pharma
7.6.1 Astellas Pharma Details
7.6.2 Astellas Pharma Major Business
7.6.3 Astellas Pharma GnRH Agonist Product and Services
7.6.4 Astellas Pharma GnRH Agonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Astellas Pharma Recent Developments/Updates
7.6.6 Astellas Pharma Competitive Strengths & Weaknesses
7.7 Takeda
7.7.1 Takeda Details
7.7.2 Takeda Major Business
7.7.3 Takeda GnRH Agonist Product and Services
7.7.4 Takeda GnRH Agonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Takeda Recent Developments/Updates
7.7.6 Takeda Competitive Strengths & Weaknesses
7.8 LIVZON
7.8.1 LIVZON Details
7.8.2 LIVZON Major Business
7.8.3 LIVZON GnRH Agonist Product and Services
7.8.4 LIVZON GnRH Agonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 LIVZON Recent Developments/Updates
7.8.6 LIVZON Competitive Strengths & Weaknesses
7.9 Ipsen
7.9.1 Ipsen Details
7.9.2 Ipsen Major Business
7.9.3 Ipsen GnRH Agonist Product and Services
7.9.4 Ipsen GnRH Agonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Ipsen Recent Developments/Updates
7.9.6 Ipsen Competitive Strengths & Weaknesses
7.10 Sanofi
7.10.1 Sanofi Details
7.10.2 Sanofi Major Business
7.10.3 Sanofi GnRH Agonist Product and Services
7.10.4 Sanofi GnRH Agonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Sanofi Recent Developments/Updates
7.10.6 Sanofi Competitive Strengths & Weaknesses
7.11 Endo
7.11.1 Endo Details
7.11.2 Endo Major Business
7.11.3 Endo GnRH Agonist Product and Services
7.11.4 Endo GnRH Agonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Endo Recent Developments/Updates
7.11.6 Endo Competitive Strengths & Weaknesses
7.12 Tocris Bioscience
7.12.1 Tocris Bioscience Details
7.12.2 Tocris Bioscience Major Business
7.12.3 Tocris Bioscience GnRH Agonist Product and Services
7.12.4 Tocris Bioscience GnRH Agonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Tocris Bioscience Recent Developments/Updates
7.12.6 Tocris Bioscience Competitive Strengths & Weaknesses
7.13 Sigma-Aldrich
7.13.1 Sigma-Aldrich Details
7.13.2 Sigma-Aldrich Major Business
7.13.3 Sigma-Aldrich GnRH Agonist Product and Services
7.13.4 Sigma-Aldrich GnRH Agonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Sigma-Aldrich Recent Developments/Updates
7.13.6 Sigma-Aldrich Competitive Strengths & Weaknesses
7.14 MedChem Express
7.14.1 MedChem Express Details
7.14.2 MedChem Express Major Business
7.14.3 MedChem Express GnRH Agonist Product and Services
7.14.4 MedChem Express GnRH Agonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 MedChem Express Recent Developments/Updates
7.14.6 MedChem Express Competitive Strengths & Weaknesses
7.15 Arbor Pharmaceuticals
7.15.1 Arbor Pharmaceuticals Details
7.15.2 Arbor Pharmaceuticals Major Business
7.15.3 Arbor Pharmaceuticals GnRH Agonist Product and Services
7.15.4 Arbor Pharmaceuticals GnRH Agonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Arbor Pharmaceuticals Recent Developments/Updates
7.15.6 Arbor Pharmaceuticals Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 GnRH Agonist Industry Chain
8.2 GnRH Agonist Upstream Analysis
8.2.1 GnRH Agonist Core Raw Materials
8.2.2 Main Manufacturers of GnRH Agonist Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 GnRH Agonist Production Mode
8.6 GnRH Agonist Procurement Model
8.7 GnRH Agonist Industry Sales Model and Sales Channels
8.7.1 GnRH Agonist Sales Model
8.7.2 GnRH Agonist Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World GnRH Agonist Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World GnRH Agonist Production Value by Region (2018-2023) & (USD Million)
Table 3. World GnRH Agonist Production Value by Region (2024-2029) & (USD Million)
Table 4. World GnRH Agonist Production Value Market Share by Region (2018-2023)
Table 5. World GnRH Agonist Production Value Market Share by Region (2024-2029)
Table 6. World GnRH Agonist Production by Region (2018-2023) & (Kilogram)
Table 7. World GnRH Agonist Production by Region (2024-2029) & (Kilogram)
Table 8. World GnRH Agonist Production Market Share by Region (2018-2023)
Table 9. World GnRH Agonist Production Market Share by Region (2024-2029)
Table 10. World GnRH Agonist Average Price by Region (2018-2023) & (US$/mg)
Table 11. World GnRH Agonist Average Price by Region (2024-2029) & (US$/mg)
Table 12. GnRH Agonist Major Market Trends
Table 13. World GnRH Agonist Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (Kilogram)
Table 14. World GnRH Agonist Consumption by Region (2018-2023) & (Kilogram)
Table 15. World GnRH Agonist Consumption Forecast by Region (2024-2029) & (Kilogram)
Table 16. World GnRH Agonist Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key GnRH Agonist Producers in 2022
Table 18. World GnRH Agonist Production by Manufacturer (2018-2023) & (Kilogram)
Table 19. Production Market Share of Key GnRH Agonist Producers in 2022
Table 20. World GnRH Agonist Average Price by Manufacturer (2018-2023) & (US$/mg)
Table 21. Global GnRH Agonist Company Evaluation Quadrant
Table 22. World GnRH Agonist Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and GnRH Agonist Production Site of Key Manufacturer
Table 24. GnRH Agonist Market: Company Product Type Footprint
Table 25. GnRH Agonist Market: Company Product Application Footprint
Table 26. GnRH Agonist Competitive Factors
Table 27. GnRH Agonist New Entrant and Capacity Expansion Plans
Table 28. GnRH Agonist Mergers & Acquisitions Activity
Table 29. United States VS China GnRH Agonist Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China GnRH Agonist Production Comparison, (2018 & 2022 & 2029) & (Kilogram)
Table 31. United States VS China GnRH Agonist Consumption Comparison, (2018 & 2022 & 2029) & (Kilogram)
Table 32. United States Based GnRH Agonist Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers GnRH Agonist Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers GnRH Agonist Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers GnRH Agonist Production (2018-2023) & (Kilogram)
Table 36. United States Based Manufacturers GnRH Agonist Production Market Share (2018-2023)
Table 37. China Based GnRH Agonist Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers GnRH Agonist Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers GnRH Agonist Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers GnRH Agonist Production (2018-2023) & (Kilogram)
Table 41. China Based Manufacturers GnRH Agonist Production Market Share (2018-2023)
Table 42. Rest of World Based GnRH Agonist Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers GnRH Agonist Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers GnRH Agonist Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers GnRH Agonist Production (2018-2023) & (Kilogram)
Table 46. Rest of World Based Manufacturers GnRH Agonist Production Market Share (2018-2023)
Table 47. World GnRH Agonist Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World GnRH Agonist Production by Type (2018-2023) & (Kilogram)
Table 49. World GnRH Agonist Production by Type (2024-2029) & (Kilogram)
Table 50. World GnRH Agonist Production Value by Type (2018-2023) & (USD Million)
Table 51. World GnRH Agonist Production Value by Type (2024-2029) & (USD Million)
Table 52. World GnRH Agonist Average Price by Type (2018-2023) & (US$/mg)
Table 53. World GnRH Agonist Average Price by Type (2024-2029) & (US$/mg)
Table 54. World GnRH Agonist Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World GnRH Agonist Production by Application (2018-2023) & (Kilogram)
Table 56. World GnRH Agonist Production by Application (2024-2029) & (Kilogram)
Table 57. World GnRH Agonist Production Value by Application (2018-2023) & (USD Million)
Table 58. World GnRH Agonist Production Value by Application (2024-2029) & (USD Million)
Table 59. World GnRH Agonist Average Price by Application (2018-2023) & (US$/mg)
Table 60. World GnRH Agonist Average Price by Application (2024-2029) & (US$/mg)
Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer Major Business
Table 63. Pfizer GnRH Agonist Product and Services
Table 64. Pfizer GnRH Agonist Production (Kilogram), Price (US$/mg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Pfizer Recent Developments/Updates
Table 66. Pfizer Competitive Strengths & Weaknesses
Table 67. AbbVie Basic Information, Manufacturing Base and Competitors
Table 68. AbbVie Major Business
Table 69. AbbVie GnRH Agonist Product and Services
Table 70. AbbVie GnRH Agonist Production (Kilogram), Price (US$/mg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. AbbVie Recent Developments/Updates
Table 72. AbbVie Competitive Strengths & Weaknesses
Table 73. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 74. AstraZeneca Major Business
Table 75. AstraZeneca GnRH Agonist Product and Services
Table 76. AstraZeneca GnRH Agonist Production (Kilogram), Price (US$/mg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. AstraZeneca Recent Developments/Updates
Table 78. AstraZeneca Competitive Strengths & Weaknesses
Table 79. Ferring Basic Information, Manufacturing Base and Competitors
Table 80. Ferring Major Business
Table 81. Ferring GnRH Agonist Product and Services
Table 82. Ferring GnRH Agonist Production (Kilogram), Price (US$/mg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Ferring Recent Developments/Updates
Table 84. Ferring Competitive Strengths & Weaknesses
Table 85. TerSera Therapeutics Basic Information, Manufacturing Base and Competitors
Table 86. TerSera Therapeutics Major Business
Table 87. TerSera Therapeutics GnRH Agonist Product and Services
Table 88. TerSera Therapeutics GnRH Agonist Production (Kilogram), Price (US$/mg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. TerSera Therapeutics Recent Developments/Updates
Table 90. TerSera Therapeutics Competitive Strengths & Weaknesses
Table 91. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 92. Astellas Pharma Major Business
Table 93. Astellas Pharma GnRH Agonist Product and Services
Table 94. Astellas Pharma GnRH Agonist Production (Kilogram), Price (US$/mg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Astellas Pharma Recent Developments/Updates
Table 96. Astellas Pharma Competitive Strengths & Weaknesses
Table 97. Takeda Basic Information, Manufacturing Base and Competitors
Table 98. Takeda Major Business
Table 99. Takeda GnRH Agonist Product and Services
Table 100. Takeda GnRH Agonist Production (Kilogram), Price (US$/mg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Takeda Recent Developments/Updates
Table 102. Takeda Competitive Strengths & Weaknesses
Table 103. LIVZON Basic Information, Manufacturing Base and Competitors
Table 104. LIVZON Major Business
Table 105. LIVZON GnRH Agonist Product and Services
Table 106. LIVZON GnRH Agonist Production (Kilogram), Price (US$/mg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. LIVZON Recent Developments/Updates
Table 108. LIVZON Competitive Strengths & Weaknesses
Table 109. Ipsen Basic Information, Manufacturing Base and Competitors
Table 110. Ipsen Major Business
Table 111. Ipsen GnRH Agonist Product and Services
Table 112. Ipsen GnRH Agonist Production (Kilogram), Price (US$/mg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Ipsen Recent Developments/Updates
Table 114. Ipsen Competitive Strengths & Weaknesses
Table 115. Sanofi Basic Information, Manufacturing Base and Competitors
Table 116. Sanofi Major Business
Table 117. Sanofi GnRH Agonist Product and Services
Table 118. Sanofi GnRH Agonist Production (Kilogram), Price (US$/mg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Sanofi Recent Developments/Updates
Table 120. Sanofi Competitive Strengths & Weaknesses
Table 121. Endo Basic Information, Manufacturing Base and Competitors
Table 122. Endo Major Business
Table 123. Endo GnRH Agonist Product and Services
Table 124. Endo GnRH Agonist Production (Kilogram), Price (US$/mg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Endo Recent Developments/Updates
Table 126. Endo Competitive Strengths & Weaknesses
Table 127. Tocris Bioscience Basic Information, Manufacturing Base and Competitors
Table 128. Tocris Bioscience Major Business
Table 129. Tocris Bioscience GnRH Agonist Product and Services
Table 130. Tocris Bioscience GnRH Agonist Production (Kilogram), Price (US$/mg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Tocris Bioscience Recent Developments/Updates
Table 132. Tocris Bioscience Competitive Strengths & Weaknesses
Table 133. Sigma-Aldrich Basic Information, Manufacturing Base and Competitors
Table 134. Sigma-Aldrich Major Business
Table 135. Sigma-Aldrich GnRH Agonist Product and Services
Table 136. Sigma-Aldrich GnRH Agonist Production (Kilogram), Price (US$/mg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Sigma-Aldrich Recent Developments/Updates
Table 138. Sigma-Aldrich Competitive Strengths & Weaknesses
Table 139. MedChem Express Basic Information, Manufacturing Base and Competitors
Table 140. MedChem Express Major Business
Table 141. MedChem Express GnRH Agonist Product and Services
Table 142. MedChem Express GnRH Agonist Production (Kilogram), Price (US$/mg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. MedChem Express Recent Developments/Updates
Table 144. Arbor Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 145. Arbor Pharmaceuticals Major Business
Table 146. Arbor Pharmaceuticals GnRH Agonist Product and Services
Table 147. Arbor Pharmaceuticals GnRH Agonist Production (Kilogram), Price (US$/mg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 148. Global Key Players of GnRH Agonist Upstream (Raw Materials)
Table 149. GnRH Agonist Typical Customers
Table 150. GnRH Agonist Typical Distributors
Table 1. World GnRH Agonist Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World GnRH Agonist Production Value by Region (2018-2023) & (USD Million)
Table 3. World GnRH Agonist Production Value by Region (2024-2029) & (USD Million)
Table 4. World GnRH Agonist Production Value Market Share by Region (2018-2023)
Table 5. World GnRH Agonist Production Value Market Share by Region (2024-2029)
Table 6. World GnRH Agonist Production by Region (2018-2023) & (Kilogram)
Table 7. World GnRH Agonist Production by Region (2024-2029) & (Kilogram)
Table 8. World GnRH Agonist Production Market Share by Region (2018-2023)
Table 9. World GnRH Agonist Production Market Share by Region (2024-2029)
Table 10. World GnRH Agonist Average Price by Region (2018-2023) & (US$/mg)
Table 11. World GnRH Agonist Average Price by Region (2024-2029) & (US$/mg)
Table 12. GnRH Agonist Major Market Trends
Table 13. World GnRH Agonist Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (Kilogram)
Table 14. World GnRH Agonist Consumption by Region (2018-2023) & (Kilogram)
Table 15. World GnRH Agonist Consumption Forecast by Region (2024-2029) & (Kilogram)
Table 16. World GnRH Agonist Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key GnRH Agonist Producers in 2022
Table 18. World GnRH Agonist Production by Manufacturer (2018-2023) & (Kilogram)
Table 19. Production Market Share of Key GnRH Agonist Producers in 2022
Table 20. World GnRH Agonist Average Price by Manufacturer (2018-2023) & (US$/mg)
Table 21. Global GnRH Agonist Company Evaluation Quadrant
Table 22. World GnRH Agonist Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and GnRH Agonist Production Site of Key Manufacturer
Table 24. GnRH Agonist Market: Company Product Type Footprint
Table 25. GnRH Agonist Market: Company Product Application Footprint
Table 26. GnRH Agonist Competitive Factors
Table 27. GnRH Agonist New Entrant and Capacity Expansion Plans
Table 28. GnRH Agonist Mergers & Acquisitions Activity
Table 29. United States VS China GnRH Agonist Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China GnRH Agonist Production Comparison, (2018 & 2022 & 2029) & (Kilogram)
Table 31. United States VS China GnRH Agonist Consumption Comparison, (2018 & 2022 & 2029) & (Kilogram)
Table 32. United States Based GnRH Agonist Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers GnRH Agonist Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers GnRH Agonist Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers GnRH Agonist Production (2018-2023) & (Kilogram)
Table 36. United States Based Manufacturers GnRH Agonist Production Market Share (2018-2023)
Table 37. China Based GnRH Agonist Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers GnRH Agonist Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers GnRH Agonist Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers GnRH Agonist Production (2018-2023) & (Kilogram)
Table 41. China Based Manufacturers GnRH Agonist Production Market Share (2018-2023)
Table 42. Rest of World Based GnRH Agonist Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers GnRH Agonist Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers GnRH Agonist Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers GnRH Agonist Production (2018-2023) & (Kilogram)
Table 46. Rest of World Based Manufacturers GnRH Agonist Production Market Share (2018-2023)
Table 47. World GnRH Agonist Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World GnRH Agonist Production by Type (2018-2023) & (Kilogram)
Table 49. World GnRH Agonist Production by Type (2024-2029) & (Kilogram)
Table 50. World GnRH Agonist Production Value by Type (2018-2023) & (USD Million)
Table 51. World GnRH Agonist Production Value by Type (2024-2029) & (USD Million)
Table 52. World GnRH Agonist Average Price by Type (2018-2023) & (US$/mg)
Table 53. World GnRH Agonist Average Price by Type (2024-2029) & (US$/mg)
Table 54. World GnRH Agonist Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World GnRH Agonist Production by Application (2018-2023) & (Kilogram)
Table 56. World GnRH Agonist Production by Application (2024-2029) & (Kilogram)
Table 57. World GnRH Agonist Production Value by Application (2018-2023) & (USD Million)
Table 58. World GnRH Agonist Production Value by Application (2024-2029) & (USD Million)
Table 59. World GnRH Agonist Average Price by Application (2018-2023) & (US$/mg)
Table 60. World GnRH Agonist Average Price by Application (2024-2029) & (US$/mg)
Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer Major Business
Table 63. Pfizer GnRH Agonist Product and Services
Table 64. Pfizer GnRH Agonist Production (Kilogram), Price (US$/mg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Pfizer Recent Developments/Updates
Table 66. Pfizer Competitive Strengths & Weaknesses
Table 67. AbbVie Basic Information, Manufacturing Base and Competitors
Table 68. AbbVie Major Business
Table 69. AbbVie GnRH Agonist Product and Services
Table 70. AbbVie GnRH Agonist Production (Kilogram), Price (US$/mg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. AbbVie Recent Developments/Updates
Table 72. AbbVie Competitive Strengths & Weaknesses
Table 73. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 74. AstraZeneca Major Business
Table 75. AstraZeneca GnRH Agonist Product and Services
Table 76. AstraZeneca GnRH Agonist Production (Kilogram), Price (US$/mg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. AstraZeneca Recent Developments/Updates
Table 78. AstraZeneca Competitive Strengths & Weaknesses
Table 79. Ferring Basic Information, Manufacturing Base and Competitors
Table 80. Ferring Major Business
Table 81. Ferring GnRH Agonist Product and Services
Table 82. Ferring GnRH Agonist Production (Kilogram), Price (US$/mg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Ferring Recent Developments/Updates
Table 84. Ferring Competitive Strengths & Weaknesses
Table 85. TerSera Therapeutics Basic Information, Manufacturing Base and Competitors
Table 86. TerSera Therapeutics Major Business
Table 87. TerSera Therapeutics GnRH Agonist Product and Services
Table 88. TerSera Therapeutics GnRH Agonist Production (Kilogram), Price (US$/mg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. TerSera Therapeutics Recent Developments/Updates
Table 90. TerSera Therapeutics Competitive Strengths & Weaknesses
Table 91. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 92. Astellas Pharma Major Business
Table 93. Astellas Pharma GnRH Agonist Product and Services
Table 94. Astellas Pharma GnRH Agonist Production (Kilogram), Price (US$/mg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Astellas Pharma Recent Developments/Updates
Table 96. Astellas Pharma Competitive Strengths & Weaknesses
Table 97. Takeda Basic Information, Manufacturing Base and Competitors
Table 98. Takeda Major Business
Table 99. Takeda GnRH Agonist Product and Services
Table 100. Takeda GnRH Agonist Production (Kilogram), Price (US$/mg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Takeda Recent Developments/Updates
Table 102. Takeda Competitive Strengths & Weaknesses
Table 103. LIVZON Basic Information, Manufacturing Base and Competitors
Table 104. LIVZON Major Business
Table 105. LIVZON GnRH Agonist Product and Services
Table 106. LIVZON GnRH Agonist Production (Kilogram), Price (US$/mg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. LIVZON Recent Developments/Updates
Table 108. LIVZON Competitive Strengths & Weaknesses
Table 109. Ipsen Basic Information, Manufacturing Base and Competitors
Table 110. Ipsen Major Business
Table 111. Ipsen GnRH Agonist Product and Services
Table 112. Ipsen GnRH Agonist Production (Kilogram), Price (US$/mg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Ipsen Recent Developments/Updates
Table 114. Ipsen Competitive Strengths & Weaknesses
Table 115. Sanofi Basic Information, Manufacturing Base and Competitors
Table 116. Sanofi Major Business
Table 117. Sanofi GnRH Agonist Product and Services
Table 118. Sanofi GnRH Agonist Production (Kilogram), Price (US$/mg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Sanofi Recent Developments/Updates
Table 120. Sanofi Competitive Strengths & Weaknesses
Table 121. Endo Basic Information, Manufacturing Base and Competitors
Table 122. Endo Major Business
Table 123. Endo GnRH Agonist Product and Services
Table 124. Endo GnRH Agonist Production (Kilogram), Price (US$/mg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Endo Recent Developments/Updates
Table 126. Endo Competitive Strengths & Weaknesses
Table 127. Tocris Bioscience Basic Information, Manufacturing Base and Competitors
Table 128. Tocris Bioscience Major Business
Table 129. Tocris Bioscience GnRH Agonist Product and Services
Table 130. Tocris Bioscience GnRH Agonist Production (Kilogram), Price (US$/mg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Tocris Bioscience Recent Developments/Updates
Table 132. Tocris Bioscience Competitive Strengths & Weaknesses
Table 133. Sigma-Aldrich Basic Information, Manufacturing Base and Competitors
Table 134. Sigma-Aldrich Major Business
Table 135. Sigma-Aldrich GnRH Agonist Product and Services
Table 136. Sigma-Aldrich GnRH Agonist Production (Kilogram), Price (US$/mg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Sigma-Aldrich Recent Developments/Updates
Table 138. Sigma-Aldrich Competitive Strengths & Weaknesses
Table 139. MedChem Express Basic Information, Manufacturing Base and Competitors
Table 140. MedChem Express Major Business
Table 141. MedChem Express GnRH Agonist Product and Services
Table 142. MedChem Express GnRH Agonist Production (Kilogram), Price (US$/mg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. MedChem Express Recent Developments/Updates
Table 144. Arbor Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 145. Arbor Pharmaceuticals Major Business
Table 146. Arbor Pharmaceuticals GnRH Agonist Product and Services
Table 147. Arbor Pharmaceuticals GnRH Agonist Production (Kilogram), Price (US$/mg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 148. Global Key Players of GnRH Agonist Upstream (Raw Materials)
Table 149. GnRH Agonist Typical Customers
Table 150. GnRH Agonist Typical Distributors
LIST OF FIGURES
Figure 1. GnRH Agonist Picture
Figure 2. World GnRH Agonist Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World GnRH Agonist Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World GnRH Agonist Production (2018-2029) & (Kilogram)
Figure 5. World GnRH Agonist Average Price (2018-2029) & (US$/mg)
Figure 6. World GnRH Agonist Production Value Market Share by Region (2018-2029)
Figure 7. World GnRH Agonist Production Market Share by Region (2018-2029)
Figure 8. North America GnRH Agonist Production (2018-2029) & (Kilogram)
Figure 9. Europe GnRH Agonist Production (2018-2029) & (Kilogram)
Figure 10. China GnRH Agonist Production (2018-2029) & (Kilogram)
Figure 11. Japan GnRH Agonist Production (2018-2029) & (Kilogram)
Figure 12. GnRH Agonist Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World GnRH Agonist Consumption (2018-2029) & (Kilogram)
Figure 15. World GnRH Agonist Consumption Market Share by Region (2018-2029)
Figure 16. United States GnRH Agonist Consumption (2018-2029) & (Kilogram)
Figure 17. China GnRH Agonist Consumption (2018-2029) & (Kilogram)
Figure 18. Europe GnRH Agonist Consumption (2018-2029) & (Kilogram)
Figure 19. Japan GnRH Agonist Consumption (2018-2029) & (Kilogram)
Figure 20. South Korea GnRH Agonist Consumption (2018-2029) & (Kilogram)
Figure 21. ASEAN GnRH Agonist Consumption (2018-2029) & (Kilogram)
Figure 22. India GnRH Agonist Consumption (2018-2029) & (Kilogram)
Figure 23. Producer Shipments of GnRH Agonist by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for GnRH Agonist Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for GnRH Agonist Markets in 2022
Figure 26. United States VS China: GnRH Agonist Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: GnRH Agonist Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: GnRH Agonist Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers GnRH Agonist Production Market Share 2022
Figure 30. China Based Manufacturers GnRH Agonist Production Market Share 2022
Figure 31. Rest of World Based Manufacturers GnRH Agonist Production Market Share 2022
Figure 32. World GnRH Agonist Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World GnRH Agonist Production Value Market Share by Type in 2022
Figure 34. Prostap
Figure 35. Zoladex
Figure 36. Triptorelin
Figure 37. Histrelin
Figure 38. Nafarelin
Figure 39. Others
Figure 40. World GnRH Agonist Production Market Share by Type (2018-2029)
Figure 41. World GnRH Agonist Production Value Market Share by Type (2018-2029)
Figure 42. World GnRH Agonist Average Price by Type (2018-2029) & (US$/mg)
Figure 43. World GnRH Agonist Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 44. World GnRH Agonist Production Value Market Share by Application in 2022
Figure 45. For Human
Figure 46. For Veterinary
Figure 47. World GnRH Agonist Production Market Share by Application (2018-2029)
Figure 48. World GnRH Agonist Production Value Market Share by Application (2018-2029)
Figure 49. World GnRH Agonist Average Price by Application (2018-2029) & (US$/mg)
Figure 50. GnRH Agonist Industry Chain
Figure 51. GnRH Agonist Procurement Model
Figure 52. GnRH Agonist Sales Model
Figure 53. GnRH Agonist Sales Channels, Direct Sales, and Distribution
Figure 54. Methodology
Figure 55. Research Process and Data Source
Figure 1. GnRH Agonist Picture
Figure 2. World GnRH Agonist Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World GnRH Agonist Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World GnRH Agonist Production (2018-2029) & (Kilogram)
Figure 5. World GnRH Agonist Average Price (2018-2029) & (US$/mg)
Figure 6. World GnRH Agonist Production Value Market Share by Region (2018-2029)
Figure 7. World GnRH Agonist Production Market Share by Region (2018-2029)
Figure 8. North America GnRH Agonist Production (2018-2029) & (Kilogram)
Figure 9. Europe GnRH Agonist Production (2018-2029) & (Kilogram)
Figure 10. China GnRH Agonist Production (2018-2029) & (Kilogram)
Figure 11. Japan GnRH Agonist Production (2018-2029) & (Kilogram)
Figure 12. GnRH Agonist Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World GnRH Agonist Consumption (2018-2029) & (Kilogram)
Figure 15. World GnRH Agonist Consumption Market Share by Region (2018-2029)
Figure 16. United States GnRH Agonist Consumption (2018-2029) & (Kilogram)
Figure 17. China GnRH Agonist Consumption (2018-2029) & (Kilogram)
Figure 18. Europe GnRH Agonist Consumption (2018-2029) & (Kilogram)
Figure 19. Japan GnRH Agonist Consumption (2018-2029) & (Kilogram)
Figure 20. South Korea GnRH Agonist Consumption (2018-2029) & (Kilogram)
Figure 21. ASEAN GnRH Agonist Consumption (2018-2029) & (Kilogram)
Figure 22. India GnRH Agonist Consumption (2018-2029) & (Kilogram)
Figure 23. Producer Shipments of GnRH Agonist by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for GnRH Agonist Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for GnRH Agonist Markets in 2022
Figure 26. United States VS China: GnRH Agonist Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: GnRH Agonist Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: GnRH Agonist Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers GnRH Agonist Production Market Share 2022
Figure 30. China Based Manufacturers GnRH Agonist Production Market Share 2022
Figure 31. Rest of World Based Manufacturers GnRH Agonist Production Market Share 2022
Figure 32. World GnRH Agonist Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World GnRH Agonist Production Value Market Share by Type in 2022
Figure 34. Prostap
Figure 35. Zoladex
Figure 36. Triptorelin
Figure 37. Histrelin
Figure 38. Nafarelin
Figure 39. Others
Figure 40. World GnRH Agonist Production Market Share by Type (2018-2029)
Figure 41. World GnRH Agonist Production Value Market Share by Type (2018-2029)
Figure 42. World GnRH Agonist Average Price by Type (2018-2029) & (US$/mg)
Figure 43. World GnRH Agonist Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 44. World GnRH Agonist Production Value Market Share by Application in 2022
Figure 45. For Human
Figure 46. For Veterinary
Figure 47. World GnRH Agonist Production Market Share by Application (2018-2029)
Figure 48. World GnRH Agonist Production Value Market Share by Application (2018-2029)
Figure 49. World GnRH Agonist Average Price by Application (2018-2029) & (US$/mg)
Figure 50. GnRH Agonist Industry Chain
Figure 51. GnRH Agonist Procurement Model
Figure 52. GnRH Agonist Sales Model
Figure 53. GnRH Agonist Sales Channels, Direct Sales, and Distribution
Figure 54. Methodology
Figure 55. Research Process and Data Source
